Literature DB >> 17642888

Diltiazem vs. nifedipine in chilblains: a clinical trial.

A K Patra1, A L Das, P Ramadasan.   

Abstract

BACKGROUND: The treatment of chilblains remains unsatisfactory. Nifedipine in higher doses remains the mainstay of treatment. AIMS: To compare the efficacy of diltiazem with that of nifedipine, and to determine the efficacy of nifedipine in lower doses, 36 chilblains cases were studied.
MATERIAL AND METHODS: Group A (12 patients) was treated with diltiazem 60 mg thrice daily, and Group B (24 patients) with 10 mg nifedipine thrice daily till complete relief and then maintained on a sustained release preparation of nifedipine 20 mg twice daily.
RESULTS: Two patients in Group A showed complete relief in 7 days, and 3 patients in about 21 days, but in 7 cases there was little or no response. In group B, 21 cases showed 80-90% relief by the fourteenth day.
CONCLUSIONS: We conclude that nifedipine remains the drug of choice in chilblains but can be used in a smaller dosage in the Indian population. Diltiazem is less effective in the conventional dose, which may be optimized.

Entities:  

Year:  2003        PMID: 17642888

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  6 in total

1.  Pernio (chilblains).

Authors:  Amjad Almahameed; Duane S Pinto
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04

2.  Nifedipine vs Placebo for Treatment of Chronic Chilblains: A Randomized Controlled Trial.

Authors:  Ibo H Souwer; Jacobus H J Bor; Paul Smits; Antoine L M Lagro-Janssen
Journal:  Ann Fam Med       Date:  2016-09       Impact factor: 5.166

3.  Pattern of chilblains in a high altitude region of Ladakh, India.

Authors:  G K Singh; A Datta; R S Grewal; M S Suresh; S S Vaishampayan
Journal:  Med J Armed Forces India       Date:  2013-05-10

4.  Perniosis (chilblains) masquerading as CA-MRSA: a case report.

Authors:  Keith D Bohman; Thomas J Papadimos; Lorie D Gottwald; Zhixing K Pan
Journal:  Cases J       Date:  2009-05-29

5.  Chilblains in immune mediated inflammatory diseases: a review.

Authors:  Shirish Dubey; Nilay Joshi; Olivia Stevenson; Caroline Gordon; John A Reynolds
Journal:  Rheumatology (Oxford)       Date:  2022-04-12       Impact factor: 7.046

6.  Pharmacologic Treatment of Idiopathic Chilblains (Pernio): A Systematic Review.

Authors:  Michelle Pratt; Farhan Mahmood; Mark G Kirchhof
Journal:  J Cutan Med Surg       Date:  2021-03-02       Impact factor: 2.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.